CY1114492T1 - Συνδυασμος αλφα 7 νικοτινικων αγωνιστων και αντιψυχωσικων - Google Patents
Συνδυασμος αλφα 7 νικοτινικων αγωνιστων και αντιψυχωσικωνInfo
- Publication number
- CY1114492T1 CY1114492T1 CY20131100896T CY131100896T CY1114492T1 CY 1114492 T1 CY1114492 T1 CY 1114492T1 CY 20131100896 T CY20131100896 T CY 20131100896T CY 131100896 T CY131100896 T CY 131100896T CY 1114492 T1 CY1114492 T1 CY 1114492T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antipsychotic
- fighters
- nicotine
- alpha combination
- alpha
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title 1
- 230000000561 anti-psychotic effect Effects 0.000 title 1
- 229960002715 nicotine Drugs 0.000 title 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 239000000181 nicotinic agonist Substances 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2828208P | 2008-02-13 | 2008-02-13 | |
| EP09709577.2A EP2254598B1 (en) | 2008-02-13 | 2009-02-13 | Combination of alpha 7 nicotinic agonists and antipsychotics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1114492T1 true CY1114492T1 (el) | 2016-10-05 |
Family
ID=40902222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131100896T CY1114492T1 (el) | 2008-02-13 | 2013-10-10 | Συνδυασμος αλφα 7 νικοτινικων αγωνιστων και αντιψυχωσικων |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20110059947A1 (enExample) |
| EP (2) | EP2254598B1 (enExample) |
| JP (1) | JP2011511845A (enExample) |
| KR (1) | KR20100113163A (enExample) |
| CN (2) | CN101977628A (enExample) |
| AU (1) | AU2009214625A1 (enExample) |
| BR (1) | BRPI0907570A2 (enExample) |
| CA (1) | CA2715268A1 (enExample) |
| CO (1) | CO6290706A2 (enExample) |
| CY (1) | CY1114492T1 (enExample) |
| DK (1) | DK2254598T3 (enExample) |
| EC (1) | ECSP10010471A (enExample) |
| ES (1) | ES2430622T3 (enExample) |
| HR (1) | HRP20130749T1 (enExample) |
| IL (1) | IL207389A0 (enExample) |
| MX (1) | MX2010008875A (enExample) |
| NZ (1) | NZ587312A (enExample) |
| PL (1) | PL2254598T3 (enExample) |
| PT (1) | PT2254598E (enExample) |
| RS (1) | RS52941B (enExample) |
| RU (1) | RU2481123C2 (enExample) |
| SG (1) | SG188144A1 (enExample) |
| SI (1) | SI2254598T1 (enExample) |
| WO (1) | WO2009102962A2 (enExample) |
| ZA (1) | ZA201005999B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
| SA08290475B1 (ar) * | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| EP2619205B1 (en) | 2010-09-23 | 2017-05-17 | AbbVie Bahamas Ltd. | Monohydrate of an azaadamantane derivative |
| EP2665478A1 (en) * | 2011-01-18 | 2013-11-27 | Targacept, Inc. | Treatment of cognitive dysfunction in schizophrenia |
| US9139576B2 (en) | 2011-05-03 | 2015-09-22 | Merck Sharp & Dohme Corp. | Aminomethyl biaryl benzotriazole derivatives |
| MX2015004285A (es) * | 2012-10-02 | 2015-08-06 | Sumitomo Dainippon Pharma Co Ltd | Derivado de imidazol. |
| JP6807094B2 (ja) * | 2016-04-29 | 2021-01-06 | 国立大学法人秋田大学 | クロザピン又はその誘導体の血中薬剤濃度上昇リスク判定方法及び薬剤投与量判定方法 |
| CN110087641B (zh) | 2016-12-20 | 2024-03-12 | 罗曼治疗系统股份公司 | 含有阿塞那平和聚硅氧烷或聚异丁烯的透皮治疗系统 |
| PL3338768T3 (pl) | 2016-12-20 | 2020-05-18 | Lts Lohmann Therapie-Systeme Ag | Transdermalny system terapeutyczny zawierający asenapinę |
| CN108727416B (zh) * | 2017-04-20 | 2021-03-09 | 北京大学 | 三环杂芳香体系酰胺衍生物及其制备和用途 |
| JP2020525545A (ja) | 2017-06-26 | 2020-08-27 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム |
| CN107469087A (zh) * | 2017-09-10 | 2017-12-15 | 孙永丽 | 用于治疗精神病的制剂 |
| CN118806732A (zh) | 2018-06-20 | 2024-10-22 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| BR112020026099A2 (pt) | 2018-06-20 | 2021-03-23 | Lts Lohmann Therapie-Systeme Ag | sistema terapêutico transdérmico que contém asenapina |
| WO2022150560A1 (en) * | 2021-01-08 | 2022-07-14 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| JP2024502474A (ja) | 2021-01-08 | 2024-01-19 | アイエフエム デュー インコーポレイテッド | Ｓｔｉｎｇ活性に関連する状態を治療するための、尿素を有するヘテロ二環式化合物または類似体およびその組成物 |
| DE102022114269A1 (de) | 2022-06-07 | 2023-12-07 | Rational Aktiengesellschaft | Gargerät mit einem Selbstreinigungssystem sowie ein Verfahren zum Ändern von Reinigungsparametern für das Gargerät |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5597919A (en) * | 1995-01-06 | 1997-01-28 | Dull; Gary M. | Pyrimidinyl or Pyridinyl alkenyl amine compounds |
| US5712270A (en) | 1995-11-06 | 1998-01-27 | American Home Products Corporation | 2-arylamidothiazole derivatives with CNS activity |
| US5616716A (en) * | 1996-01-06 | 1997-04-01 | Dull; Gary M. | (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds |
| SE9600683D0 (sv) | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
| US5663356A (en) * | 1996-04-23 | 1997-09-02 | Ruecroft; Graham | Method for preparation of aryl substituted alefinic secondary amino compounds |
| AR013184A1 (es) | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| AU765142B2 (en) | 1998-06-01 | 2003-09-11 | Ortho-Mcneil Pharmaceutical, Inc. | Method for treating neurodegenerative disorders |
| US6953855B2 (en) * | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| SE9904176D0 (sv) | 1999-11-18 | 1999-11-18 | Astra Ab | New use |
| BR0016168A (pt) * | 1999-12-10 | 2002-08-20 | Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos | |
| AU2001266100B9 (en) * | 2000-06-27 | 2005-10-06 | Laboratorios S.A.L.V.A.T., S.A. | Carbamates derived from arylalkylamines |
| US6486172B2 (en) | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| US6492386B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
| AU2001282874A1 (en) | 2000-08-18 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| WO2002017358A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| WO2002015662A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| JP2004506734A (ja) | 2000-08-21 | 2004-03-04 | ファルマシア・アンド・アップジョン・カンパニー | 疾患治療用のキヌクリド置換ヘテロアリール部分 |
| US6554086B1 (en) * | 2000-10-27 | 2003-04-29 | Invacare Corporation | Obstacle traversing wheelchair |
| EP1345937B1 (en) | 2000-12-22 | 2005-09-28 | Almirall Prodesfarma AG | Quinuclidine carbamate derivatives and their use as m3 antagonists |
| CA2476624A1 (en) * | 2002-02-19 | 2003-08-28 | Pharmacia & Upjohn Company | Azabicyclic compounds for the treatment of disease |
| JP2006510664A (ja) * | 2002-12-06 | 2006-03-30 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | １−アザビシクロ［２．２．２］オクト置換フロ［２，３−ｃ］ピリジニルカルボキサミドの結晶性フマル酸塩及び該塩を含む組成物並びにその製造方法 |
| TW200502222A (en) * | 2003-04-02 | 2005-01-16 | Novartis Ag | Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
| WO2004099202A1 (en) * | 2003-05-05 | 2004-11-18 | Pharmacia & Upjohn Company Llc | Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases |
| US7309699B2 (en) * | 2003-12-22 | 2007-12-18 | Abbott Laboratories | 3-Quinuclidinyl amino-substituted biaryl derivatives |
| EP1699488A2 (en) * | 2003-12-23 | 2006-09-13 | Pfizer Products Incorporated | Therapeutic combination for cognition enhancement and psychotic disorders |
| EP1863485A2 (en) * | 2005-03-18 | 2007-12-12 | Abbott Laboratories | Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions |
-
2009
- 2009-02-13 EP EP09709577.2A patent/EP2254598B1/en active Active
- 2009-02-13 DK DK09709577.2T patent/DK2254598T3/da active
- 2009-02-13 NZ NZ587312A patent/NZ587312A/en not_active IP Right Cessation
- 2009-02-13 PT PT97095772T patent/PT2254598E/pt unknown
- 2009-02-13 SG SG2013010327A patent/SG188144A1/en unknown
- 2009-02-13 CA CA2715268A patent/CA2715268A1/en not_active Abandoned
- 2009-02-13 EP EP13167089.5A patent/EP2633868A1/en not_active Withdrawn
- 2009-02-13 HR HRP20130749AT patent/HRP20130749T1/hr unknown
- 2009-02-13 AU AU2009214625A patent/AU2009214625A1/en not_active Abandoned
- 2009-02-13 RU RU2010137787/15A patent/RU2481123C2/ru not_active IP Right Cessation
- 2009-02-13 MX MX2010008875A patent/MX2010008875A/es not_active Application Discontinuation
- 2009-02-13 SI SI200930714T patent/SI2254598T1/sl unknown
- 2009-02-13 CN CN2009801102033A patent/CN101977628A/zh active Pending
- 2009-02-13 KR KR1020107020088A patent/KR20100113163A/ko not_active Ceased
- 2009-02-13 RS RS20130387A patent/RS52941B/sr unknown
- 2009-02-13 US US12/867,073 patent/US20110059947A1/en not_active Abandoned
- 2009-02-13 PL PL09709577T patent/PL2254598T3/pl unknown
- 2009-02-13 BR BRPI0907570A patent/BRPI0907570A2/pt not_active IP Right Cessation
- 2009-02-13 WO PCT/US2009/034062 patent/WO2009102962A2/en not_active Ceased
- 2009-02-13 JP JP2010546920A patent/JP2011511845A/ja active Pending
- 2009-02-13 CN CN2013100500436A patent/CN103143023A/zh active Pending
- 2009-02-13 ES ES09709577T patent/ES2430622T3/es active Active
-
2010
- 2010-08-03 IL IL207389A patent/IL207389A0/en unknown
- 2010-08-23 ZA ZA2010/05999A patent/ZA201005999B/en unknown
- 2010-09-09 EC EC2010010471A patent/ECSP10010471A/es unknown
- 2010-09-10 CO CO10112124A patent/CO6290706A2/es not_active Application Discontinuation
-
2013
- 2013-10-10 CY CY20131100896T patent/CY1114492T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009102962A2 (en) | 2009-08-20 |
| CN101977628A (zh) | 2011-02-16 |
| PL2254598T3 (pl) | 2013-12-31 |
| EP2254598B1 (en) | 2013-07-10 |
| JP2011511845A (ja) | 2011-04-14 |
| IL207389A0 (en) | 2010-12-30 |
| PT2254598E (pt) | 2013-10-16 |
| SG188144A1 (en) | 2013-03-28 |
| CO6290706A2 (es) | 2011-06-20 |
| ES2430622T3 (es) | 2013-11-21 |
| RS52941B (sr) | 2014-02-28 |
| WO2009102962A3 (en) | 2009-10-08 |
| HRP20130749T1 (en) | 2013-10-11 |
| AU2009214625A1 (en) | 2009-08-20 |
| SI2254598T1 (sl) | 2013-10-30 |
| RU2010137787A (ru) | 2012-03-20 |
| EP2254598A2 (en) | 2010-12-01 |
| ZA201005999B (en) | 2011-05-25 |
| NZ587312A (en) | 2011-12-22 |
| KR20100113163A (ko) | 2010-10-20 |
| ECSP10010471A (es) | 2010-10-30 |
| MX2010008875A (es) | 2010-08-31 |
| DK2254598T3 (da) | 2013-07-29 |
| CA2715268A1 (en) | 2009-08-20 |
| BRPI0907570A2 (pt) | 2019-09-24 |
| CN103143023A (zh) | 2013-06-12 |
| HK1147954A1 (en) | 2011-08-26 |
| RU2481123C2 (ru) | 2013-05-10 |
| US20110059947A1 (en) | 2011-03-10 |
| EP2633868A1 (en) | 2013-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120961T1 (el) | Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος | |
| ECSP10010471A (es) | Agonistas nicotínicos alfa 7 y antipsicóticos | |
| CY1118007T1 (el) | Μεθοδοι για την χορηγηση υπογλυκαιμικων μεσων | |
| CY1119643T1 (el) | Συνδυασμοι που περιεχουν μεθοτρεξατη και αναστολεις της dhodh | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| ATE496051T1 (de) | Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten | |
| CY1110026T1 (el) | Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων | |
| AU2009303758A8 (en) | Benzoquinoline inhibitors of vesicular monoamine transporter 2 | |
| EA200900091A1 (ru) | Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний | |
| DE112007000745A5 (de) | Die Tornadormaschine - Ein Nebel-Wirbler, der als Effektgerät, Luftbefeuchter und Aerosolgenerator einsetzbar ist | |
| SV2010003631A (es) | Aril pirrolinas insecticidas | |
| BR112014012524A2 (pt) | composições compreendendo um componente de estabilidade do prazo de validade | |
| DK1776011T3 (da) | Fungicid sammensætning, indeholdende et syreamidderivat | |
| CO6210786A2 (es) | Implemento de cuidado oral que alberga un agente de cuidado oral | |
| CL2011003147A1 (es) | Compuestos derivados de n-(1-4-(1h-pirazol-5-il)ftalazina-1-il) piperidina-4-il) benzamida; composicion farmaceutica que los contiene, utiles como antagonista de la trayectoria de hedgehog, en el tratamiento del cancer. | |
| CY1113102T1 (el) | Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων | |
| CY1113435T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει παραγωγο πυραζινης, και μεθοδος χρησης παραγωγου πυραζινης σε συνδυασμο | |
| EA201170703A1 (ru) | Производные адамантилбензамида | |
| CY1113916T1 (el) | Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης | |
| DE602008005141D1 (de) | 1,3-dihydroimidazol-2-thionderivate als inhibitoren von dopamin-beta-hydroxylase | |
| CY1115437T1 (el) | Υδροξυμεθυλοκυκλοεξυλαμινες | |
| ATE458740T1 (de) | 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten | |
| BRPI0814772A2 (pt) | Indazóis substituídos por 5-piridinona | |
| MX2009013982A (es) | Composiciones que comprenden inhibidores de triptofano hidroxilasa. | |
| ATE531721T1 (de) | Cyanoaminochinolone als gsk-3-inhibitoren |